Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 70 | 0 | 0 | 1,741 |
| Gross Profit | N/A | 70 | N/A | N/A | 1,741 |
| Operating Expenses | 3,576 | 6,718 | 9,722 | 9,126 | 9,326 |
| Operating Income | -3,576 | -6,648 | -9,722 | -9,126 | -7,585 |
| Interest Expense | 858 | 1,045 | 2,971 | 2,003 | 1,998 |
| Other Income | -346 | -513 | 17,369 | 611 | -389 |
| Pre-tax Income | -4,780 | -8,206 | 4,677 | -10,517 | -9,972 |
| Net Income Continuous | -4,780 | -8,206 | 4,677 | -10,517 | -9,972 |
| Minority Interests | -256 | -303 | -418 | -1,126 | -469 |
| Net Income | $-4,524 | $-7,903 | $5,095 | $-9,391 | $-9,503 |
| EPS Basic Total Ops | -0.01 | -0.02 | 0.01 | -0.03 | -0.11 |
| EPS Basic Continuous Ops | -0.01 | -0.02 | 0.01 | -0.03 | -0.11 |
| EPS Diluted Total Ops | -0.01 | -0.02 | 0.01 | -0.03 | -0.11 |
| EPS Diluted Continuous Ops | -0.01 | -0.02 | 0.01 | -0.03 | -0.11 |
| EPS Diluted Before Non-Recurring Items | 0.00 | 0.00 | -0.03 | -0.03 | -0.11 |
| EBITDA(a) | $-254 | $-263 | $-3,622 | $-7,610 | $-5,900 |